Paul Clark
Chief Executive Officer at Lilly ICOS LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Satish Dhanasekaran | M | 51 | 10 years | |
| Robert Funck | M | 61 | 37 years | |
| Jonathan Lord | M | 69 | 10 years | |
| Jean Nye | F | 71 | 25 years | |
| Soon Chai Gooi | M | 63 | 33 years | |
| Scott House | M | - | 34 years | |
| John Chiminski | M | 60 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 15 years |
| Daniel Podolsky | M | 70 | 9 years | |
| Guillermo Gualino | M | - | 13 years | |
| Sue Rataj | F | 67 | 9 years | |
| Hans Bishop | M | 59 | 7 years | |
| Michelle Holthaus | F | 50 | 3 years | |
| Dow Wilson | M | 64 | 6 years | |
| Mikael Dolsten | M | 65 | 3 years | |
| Joanne Olsen | F | 65 | 5 years | |
| Paul Lacouture | M | 73 | 5 years | |
| Scott Leinenweber | M | - | 27 years | |
| Mala Anand | F | 56 | 5 years | |
| Robert Rango | M | 66 | 9 years | |
| Otis Brawley | M | 64 | 3 years | |
| James Cullen | M | 81 | 10 years | |
| George Scangos | M | 76 | 13 years | |
| Susan Hirsch | F | 71 | 4 years | |
| Charles Dockendorff | M | 69 | 10 years | |
| Robert McMahon | M | 55 | 6 years | |
| Philip Boudreau | M | 51 | 27 years | |
| Rick Hamada Hamada | M | 65 | 10 years | |
| Allison Ballmer | F | - | 6 years | |
| Jenipher Dalton | F | - | 4 years | |
| John Malcolm Hanson | M | 71 |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 years |
| Sergi Roura | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Steven O’Day | M | 63 | 3 years | |
| Mark Wallace | M | 59 | 8 years | |
| Andrea Wainer | F | - | 27 years | |
| Victoria Wadsworth-Hansen | F | - | 10 years | |
| Mark Pierpoint | M | - | 6 years | |
| Gerald Klein | M | 77 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 years |
| Marie Hattar | F | - | 7 years | |
| Henrik Ancher-Jensen | M | 59 | 12 years | |
| Benjamin Leahy Marshall | M | 40 |
Genstar Capital LLC
 Genstar Capital LLC Investment ManagersFinance Genstar Capital LLC engages in provision of investment consulting services. It offers investment advice to financial services, healthcare, industrial, and technology and software industries. The company was founded in 1988 and is headquartered in San Francisco, CA. | 14 years |
| Tom Beermann | M | - | 5 years | |
| Jack Stahl | M | 71 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 10 years |
| Joel E. Abelson | M | 65 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 18 years |
| Jim Engle | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 years |
| Ruedi E. Waeger | M | 80 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Eric Epstein | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Kari Heerdt | F | 57 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Thomas J. Lynch | M | 73 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 years |
| Martin Dawkins | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Michael Fournel | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Bruce Nogales | M | 67 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Sullivan | M | 74 | 16 years | |
| Alexander Arrow | M | 53 | 4 years | |
| Marie Huber | F | 62 | 13 years | |
| Didier Hirsch | M | 72 | 19 years | |
| Miles White | M | 69 | 37 years | |
| Jeffrey M. Nugent | M | 76 | 1 years | |
| George B. Rathmann | M | - |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 11 years |
| Federico Pignatelli | M | 71 | 23 years | |
| Scott L. Houlton | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 years |
| Ron Nersesian | M | 64 | 12 years | |
| Elaine R. Leavenworth | F | 65 | 27 years | |
| Sam Khichi | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 years |
| Michael C. Gasparian | M | 65 | 3 years | |
| Stephen D. Williams | M | 52 | 14 years | |
| Fred B. Parks | M | 76 | 1 years | |
| Harold C. Flynn | M | 58 | 3 years | |
| Hilliard Terry | M | 54 | 13 years | |
| David M. Lawrence | M | 83 | 15 years | |
| Norman J. Nemoy | M | 84 | 4 years | |
| Frederick D. Furry | M | 54 | 5 years | |
| Kurt R. Nielsen | M | 56 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Cornell Stamoran | M | 56 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Michael McFadden | M | 57 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Patrick W. McNallen | M | - | 5 years | |
| Brian Yoor | M | 55 | 23 years | |
| Samuel B. Low | M | - | 1 years | |
| Sriram Gollapalli | M | - | 7 years | |
| Andy Hurley | M | - | 1 years | |
| Jack Schuler | M | 83 | 17 years | |
| Thomas Joseph Dee | M | 60 | 23 years | |
| Laura Clague | F | 64 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 years |
| Adrian Dillon | M | 70 | 9 years | |
| Arthur Higgins | M | 68 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 3 years |
| D. Craig Nordlund | M | 74 | 10 years | |
| David A. L. Owen | M | 85 | - | |
| H. Fuller | M | 85 | - | |
| Roy S. Roberts | M | 84 | - | |
| Duane L. Burnham | M | 82 | 9 years | |
| Gary L. Wilcox | M | 77 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 14 years |
| Alexander Denner | M | 54 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| John B. Thomas | M | - | 18 years | |
| Steven M. Rauscher | M | 70 | 18 years | |
| A. Barry Rand | M | 79 | 15 years | |
| G. Kirk Raab | M | 88 | 4 years | |
| James Wilson | M | 80 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| David Milligan | M | 83 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 28 years |
| Mary Szela | F | 61 | 25 years | |
| Charles W. Silvey | M | 65 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Evan Kearns | M | 43 | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Clark
- Personal Network
